nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0918	0.432	CbGbCtD
Mitoxantrone—CYP3A4—Donepezil—Alzheimer's disease	0.0734	0.345	CbGbCtD
Mitoxantrone—CYP3A4—Galantamine—Alzheimer's disease	0.0473	0.223	CbGbCtD
Mitoxantrone—PIM1—forebrain—Alzheimer's disease	0.00554	0.0901	CbGeAlD
Mitoxantrone—SLC47A2—nervous system—Alzheimer's disease	0.0046	0.0749	CbGeAlD
Mitoxantrone—SLC47A2—central nervous system—Alzheimer's disease	0.00443	0.0721	CbGeAlD
Mitoxantrone—SLC47A2—brain—Alzheimer's disease	0.00352	0.0573	CbGeAlD
Mitoxantrone—PIM1—nervous system—Alzheimer's disease	0.00301	0.0489	CbGeAlD
Mitoxantrone—PIM1—central nervous system—Alzheimer's disease	0.00289	0.0471	CbGeAlD
Mitoxantrone—PIM1—cerebellum—Alzheimer's disease	0.00283	0.046	CbGeAlD
Mitoxantrone—BTK—brain—Alzheimer's disease	0.00265	0.0432	CbGeAlD
Mitoxantrone—PIM1—brain—Alzheimer's disease	0.0023	0.0374	CbGeAlD
Mitoxantrone—CYP1B1—telencephalon—Alzheimer's disease	0.002	0.0326	CbGeAlD
Mitoxantrone—ABCC1—telencephalon—Alzheimer's disease	0.0018	0.0293	CbGeAlD
Mitoxantrone—SLC47A1—nervous system—Alzheimer's disease	0.00161	0.0262	CbGeAlD
Mitoxantrone—SLC47A1—central nervous system—Alzheimer's disease	0.00155	0.0252	CbGeAlD
Mitoxantrone—SLC47A1—cerebellum—Alzheimer's disease	0.00152	0.0247	CbGeAlD
Mitoxantrone—ABCB1—blood vessel—Alzheimer's disease	0.00151	0.0246	CbGeAlD
Mitoxantrone—ABCG2—telencephalon—Alzheimer's disease	0.00149	0.0242	CbGeAlD
Mitoxantrone—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00141	0.00316	CcSEcCtD
Mitoxantrone—Pneumonia—Donepezil—Alzheimer's disease	0.0014	0.00314	CcSEcCtD
Mitoxantrone—Sweating increased—Memantine—Alzheimer's disease	0.00139	0.0031	CcSEcCtD
Mitoxantrone—Dysgeusia—Galantamine—Alzheimer's disease	0.00138	0.00308	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00138	0.00308	CcSEcCtD
Mitoxantrone—Renal failure—Donepezil—Alzheimer's disease	0.00137	0.00307	CcSEcCtD
Mitoxantrone—Myocardial infarction—Donepezil—Alzheimer's disease	0.00137	0.00306	CcSEcCtD
Mitoxantrone—Back pain—Galantamine—Alzheimer's disease	0.00136	0.00304	CcSEcCtD
Mitoxantrone—Jaundice—Donepezil—Alzheimer's disease	0.00136	0.00304	CcSEcCtD
Mitoxantrone—Conjunctivitis—Donepezil—Alzheimer's disease	0.00136	0.00303	CcSEcCtD
Mitoxantrone—Urinary tract infection—Donepezil—Alzheimer's disease	0.00136	0.00303	CcSEcCtD
Mitoxantrone—Sweating increased—Rivastigmine—Alzheimer's disease	0.00135	0.00303	CcSEcCtD
Mitoxantrone—Pancytopenia—Memantine—Alzheimer's disease	0.00135	0.00302	CcSEcCtD
Mitoxantrone—Sweating—Donepezil—Alzheimer's disease	0.00134	0.00299	CcSEcCtD
Mitoxantrone—Haematuria—Donepezil—Alzheimer's disease	0.00133	0.00298	CcSEcCtD
Mitoxantrone—Neutropenia—Memantine—Alzheimer's disease	0.00133	0.00297	CcSEcCtD
Mitoxantrone—Vision blurred—Galantamine—Alzheimer's disease	0.00133	0.00297	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00132	0.00295	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Memantine—Alzheimer's disease	0.00131	0.00293	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00131	0.00292	CcSEcCtD
Mitoxantrone—Anaemia—Galantamine—Alzheimer's disease	0.0013	0.00291	CcSEcCtD
Mitoxantrone—Weight increased—Memantine—Alzheimer's disease	0.00129	0.00289	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00129	0.00289	CcSEcCtD
Mitoxantrone—CYP2E1—telencephalon—Alzheimer's disease	0.00129	0.021	CbGeAlD
Mitoxantrone—Weight decreased—Memantine—Alzheimer's disease	0.00129	0.00288	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Memantine—Alzheimer's disease	0.00128	0.00287	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00128	0.00286	CcSEcCtD
Mitoxantrone—Bradycardia—Donepezil—Alzheimer's disease	0.00128	0.00285	CcSEcCtD
Mitoxantrone—Pneumonia—Memantine—Alzheimer's disease	0.00128	0.00285	CcSEcCtD
Mitoxantrone—Malaise—Galantamine—Alzheimer's disease	0.00127	0.00284	CcSEcCtD
Mitoxantrone—Weight increased—Rivastigmine—Alzheimer's disease	0.00127	0.00283	CcSEcCtD
Mitoxantrone—Haemoglobin—Donepezil—Alzheimer's disease	0.00126	0.00282	CcSEcCtD
Mitoxantrone—Weight decreased—Rivastigmine—Alzheimer's disease	0.00126	0.00281	CcSEcCtD
Mitoxantrone—Rhinitis—Donepezil—Alzheimer's disease	0.00126	0.00281	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00125	0.00281	CcSEcCtD
Mitoxantrone—Haemorrhage—Donepezil—Alzheimer's disease	0.00125	0.0028	CcSEcCtD
Mitoxantrone—Hepatitis—Donepezil—Alzheimer's disease	0.00125	0.0028	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00125	0.00279	CcSEcCtD
Mitoxantrone—Pneumonia—Rivastigmine—Alzheimer's disease	0.00125	0.00279	CcSEcCtD
Mitoxantrone—Renal failure—Memantine—Alzheimer's disease	0.00125	0.00279	CcSEcCtD
Mitoxantrone—Pharyngitis—Donepezil—Alzheimer's disease	0.00124	0.00278	CcSEcCtD
Mitoxantrone—Myocardial infarction—Memantine—Alzheimer's disease	0.00124	0.00278	CcSEcCtD
Mitoxantrone—Drowsiness—Rivastigmine—Alzheimer's disease	0.00124	0.00277	CcSEcCtD
Mitoxantrone—Urinary tract infection—Memantine—Alzheimer's disease	0.00123	0.00276	CcSEcCtD
Mitoxantrone—Conjunctivitis—Memantine—Alzheimer's disease	0.00123	0.00276	CcSEcCtD
Mitoxantrone—SLC47A1—brain—Alzheimer's disease	0.00123	0.02	CbGeAlD
Mitoxantrone—Cough—Galantamine—Alzheimer's disease	0.00123	0.00275	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00122	0.00273	CcSEcCtD
Mitoxantrone—Convulsion—Galantamine—Alzheimer's disease	0.00122	0.00273	CcSEcCtD
Mitoxantrone—Renal failure—Rivastigmine—Alzheimer's disease	0.00122	0.00273	CcSEcCtD
Mitoxantrone—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00122	0.00272	CcSEcCtD
Mitoxantrone—Hypertension—Galantamine—Alzheimer's disease	0.00122	0.00272	CcSEcCtD
Mitoxantrone—Haematuria—Memantine—Alzheimer's disease	0.00121	0.0027	CcSEcCtD
Mitoxantrone—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00121	0.0027	CcSEcCtD
Mitoxantrone—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00121	0.0027	CcSEcCtD
Mitoxantrone—Myalgia—Galantamine—Alzheimer's disease	0.0012	0.00268	CcSEcCtD
Mitoxantrone—Chest pain—Galantamine—Alzheimer's disease	0.0012	0.00268	CcSEcCtD
Mitoxantrone—Arthralgia—Galantamine—Alzheimer's disease	0.0012	0.00268	CcSEcCtD
Mitoxantrone—Anxiety—Galantamine—Alzheimer's disease	0.00119	0.00267	CcSEcCtD
Mitoxantrone—Sinusitis—Memantine—Alzheimer's disease	0.00119	0.00266	CcSEcCtD
Mitoxantrone—Sweating—Rivastigmine—Alzheimer's disease	0.00119	0.00266	CcSEcCtD
Mitoxantrone—Discomfort—Galantamine—Alzheimer's disease	0.00118	0.00265	CcSEcCtD
Mitoxantrone—Agranulocytosis—Memantine—Alzheimer's disease	0.00118	0.00265	CcSEcCtD
Mitoxantrone—Haematuria—Rivastigmine—Alzheimer's disease	0.00118	0.00264	CcSEcCtD
Mitoxantrone—CYP1B1—nervous system—Alzheimer's disease	0.00118	0.0192	CbGeAlD
Mitoxantrone—Sinusitis—Rivastigmine—Alzheimer's disease	0.00116	0.0026	CcSEcCtD
Mitoxantrone—Confusional state—Galantamine—Alzheimer's disease	0.00116	0.00259	CcSEcCtD
Mitoxantrone—Bradycardia—Memantine—Alzheimer's disease	0.00116	0.00259	CcSEcCtD
Mitoxantrone—Haemoglobin—Memantine—Alzheimer's disease	0.00114	0.00256	CcSEcCtD
Mitoxantrone—Rhinitis—Memantine—Alzheimer's disease	0.00114	0.00255	CcSEcCtD
Mitoxantrone—Haemorrhage—Memantine—Alzheimer's disease	0.00114	0.00254	CcSEcCtD
Mitoxantrone—Hepatitis—Memantine—Alzheimer's disease	0.00114	0.00254	CcSEcCtD
Mitoxantrone—CYP1B1—central nervous system—Alzheimer's disease	0.00114	0.0185	CbGeAlD
Mitoxantrone—Bradycardia—Rivastigmine—Alzheimer's disease	0.00113	0.00253	CcSEcCtD
Mitoxantrone—Shock—Galantamine—Alzheimer's disease	0.00113	0.00253	CcSEcCtD
Mitoxantrone—Pharyngitis—Memantine—Alzheimer's disease	0.00113	0.00253	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00113	0.00252	CcSEcCtD
Mitoxantrone—Chills—Donepezil—Alzheimer's disease	0.00112	0.00251	CcSEcCtD
Mitoxantrone—Tachycardia—Galantamine—Alzheimer's disease	0.00112	0.00251	CcSEcCtD
Mitoxantrone—Arrhythmia—Donepezil—Alzheimer's disease	0.00112	0.0025	CcSEcCtD
Mitoxantrone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00112	0.0025	CcSEcCtD
Mitoxantrone—Rhinitis—Rivastigmine—Alzheimer's disease	0.00112	0.0025	CcSEcCtD
Mitoxantrone—Skin disorder—Galantamine—Alzheimer's disease	0.00112	0.0025	CcSEcCtD
Mitoxantrone—Hepatitis—Rivastigmine—Alzheimer's disease	0.00111	0.00249	CcSEcCtD
Mitoxantrone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00111	0.00249	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00111	0.00248	CcSEcCtD
Mitoxantrone—CYP1B1—cerebellum—Alzheimer's disease	0.00111	0.0181	CbGeAlD
Mitoxantrone—Alopecia—Donepezil—Alzheimer's disease	0.00111	0.00248	CcSEcCtD
Mitoxantrone—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00111	0.00247	CcSEcCtD
Mitoxantrone—Anorexia—Galantamine—Alzheimer's disease	0.0011	0.00245	CcSEcCtD
Mitoxantrone—Erythema—Donepezil—Alzheimer's disease	0.00109	0.00244	CcSEcCtD
Mitoxantrone—Hypotension—Galantamine—Alzheimer's disease	0.00107	0.0024	CcSEcCtD
Mitoxantrone—Dysgeusia—Donepezil—Alzheimer's disease	0.00107	0.00239	CcSEcCtD
Mitoxantrone—Back pain—Donepezil—Alzheimer's disease	0.00106	0.00236	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00105	0.00234	CcSEcCtD
Mitoxantrone—Paraesthesia—Galantamine—Alzheimer's disease	0.00103	0.00231	CcSEcCtD
Mitoxantrone—Vision blurred—Donepezil—Alzheimer's disease	0.00103	0.0023	CcSEcCtD
Mitoxantrone—Somnolence—Galantamine—Alzheimer's disease	0.00102	0.00228	CcSEcCtD
Mitoxantrone—Chills—Memantine—Alzheimer's disease	0.00102	0.00228	CcSEcCtD
Mitoxantrone—Arrhythmia—Memantine—Alzheimer's disease	0.00102	0.00227	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00101	0.00226	CcSEcCtD
Mitoxantrone—Dyspepsia—Galantamine—Alzheimer's disease	0.00101	0.00226	CcSEcCtD
Mitoxantrone—Anaemia—Donepezil—Alzheimer's disease	0.00101	0.00225	CcSEcCtD
Mitoxantrone—Alopecia—Memantine—Alzheimer's disease	0.00101	0.00225	CcSEcCtD
Mitoxantrone—ABCC1—cerebellum—Alzheimer's disease	0.000999	0.0163	CbGeAlD
Mitoxantrone—Chills—Rivastigmine—Alzheimer's disease	0.000999	0.00223	CcSEcCtD
Mitoxantrone—Decreased appetite—Galantamine—Alzheimer's disease	0.000999	0.00223	CcSEcCtD
Mitoxantrone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000995	0.00222	CcSEcCtD
Mitoxantrone—Fatigue—Galantamine—Alzheimer's disease	0.000991	0.00221	CcSEcCtD
Mitoxantrone—Malaise—Donepezil—Alzheimer's disease	0.000984	0.0022	CcSEcCtD
Mitoxantrone—Alopecia—Rivastigmine—Alzheimer's disease	0.000984	0.0022	CcSEcCtD
Mitoxantrone—Constipation—Galantamine—Alzheimer's disease	0.000983	0.0022	CcSEcCtD
Mitoxantrone—Dysgeusia—Memantine—Alzheimer's disease	0.00097	0.00217	CcSEcCtD
Mitoxantrone—Erythema—Rivastigmine—Alzheimer's disease	0.000969	0.00217	CcSEcCtD
Mitoxantrone—Back pain—Memantine—Alzheimer's disease	0.000958	0.00214	CcSEcCtD
Mitoxantrone—Cough—Donepezil—Alzheimer's disease	0.000952	0.00213	CcSEcCtD
Mitoxantrone—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000949	0.00212	CcSEcCtD
Mitoxantrone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000947	0.00212	CcSEcCtD
Mitoxantrone—Convulsion—Donepezil—Alzheimer's disease	0.000945	0.00211	CcSEcCtD
Mitoxantrone—Hypertension—Donepezil—Alzheimer's disease	0.000942	0.00211	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00094	0.0021	CcSEcCtD
Mitoxantrone—Back pain—Rivastigmine—Alzheimer's disease	0.000938	0.0021	CcSEcCtD
Mitoxantrone—Vision blurred—Memantine—Alzheimer's disease	0.000934	0.00209	CcSEcCtD
Mitoxantrone—Myalgia—Donepezil—Alzheimer's disease	0.000929	0.00208	CcSEcCtD
Mitoxantrone—Chest pain—Donepezil—Alzheimer's disease	0.000929	0.00208	CcSEcCtD
Mitoxantrone—Arthralgia—Donepezil—Alzheimer's disease	0.000929	0.00208	CcSEcCtD
Mitoxantrone—Anxiety—Donepezil—Alzheimer's disease	0.000926	0.00207	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000919	0.00206	CcSEcCtD
Mitoxantrone—Discomfort—Donepezil—Alzheimer's disease	0.000918	0.00205	CcSEcCtD
Mitoxantrone—Anaemia—Memantine—Alzheimer's disease	0.000916	0.00205	CcSEcCtD
Mitoxantrone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000913	0.00204	CcSEcCtD
Mitoxantrone—Abdominal pain—Galantamine—Alzheimer's disease	0.000908	0.00203	CcSEcCtD
Mitoxantrone—Body temperature increased—Galantamine—Alzheimer's disease	0.000908	0.00203	CcSEcCtD
Mitoxantrone—ABCB1—embryo—Alzheimer's disease	0.000903	0.0147	CbGeAlD
Mitoxantrone—CYP1B1—brain—Alzheimer's disease	0.000902	0.0147	CbGeAlD
Mitoxantrone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000899	0.00201	CcSEcCtD
Mitoxantrone—Confusional state—Donepezil—Alzheimer's disease	0.000898	0.00201	CcSEcCtD
Mitoxantrone—Anaemia—Rivastigmine—Alzheimer's disease	0.000896	0.002	CcSEcCtD
Mitoxantrone—Malaise—Memantine—Alzheimer's disease	0.000893	0.002	CcSEcCtD
Mitoxantrone—Oedema—Donepezil—Alzheimer's disease	0.000891	0.00199	CcSEcCtD
Mitoxantrone—Leukopenia—Memantine—Alzheimer's disease	0.000887	0.00198	CcSEcCtD
Mitoxantrone—Infection—Donepezil—Alzheimer's disease	0.000885	0.00198	CcSEcCtD
Mitoxantrone—Shock—Donepezil—Alzheimer's disease	0.000876	0.00196	CcSEcCtD
Mitoxantrone—Malaise—Rivastigmine—Alzheimer's disease	0.000874	0.00195	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000872	0.00195	CcSEcCtD
Mitoxantrone—Cough—Memantine—Alzheimer's disease	0.000865	0.00193	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000861	0.00192	CcSEcCtD
Mitoxantrone—Convulsion—Memantine—Alzheimer's disease	0.000858	0.00192	CcSEcCtD
Mitoxantrone—Hypertension—Memantine—Alzheimer's disease	0.000855	0.00191	CcSEcCtD
Mitoxantrone—Anorexia—Donepezil—Alzheimer's disease	0.000849	0.0019	CcSEcCtD
Mitoxantrone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000847	0.00189	CcSEcCtD
Mitoxantrone—Cough—Rivastigmine—Alzheimer's disease	0.000846	0.00189	CcSEcCtD
Mitoxantrone—Chest pain—Memantine—Alzheimer's disease	0.000843	0.00189	CcSEcCtD
Mitoxantrone—Myalgia—Memantine—Alzheimer's disease	0.000843	0.00189	CcSEcCtD
Mitoxantrone—Arthralgia—Memantine—Alzheimer's disease	0.000843	0.00189	CcSEcCtD
Mitoxantrone—Anxiety—Memantine—Alzheimer's disease	0.000841	0.00188	CcSEcCtD
Mitoxantrone—Convulsion—Rivastigmine—Alzheimer's disease	0.00084	0.00188	CcSEcCtD
Mitoxantrone—Hypertension—Rivastigmine—Alzheimer's disease	0.000837	0.00187	CcSEcCtD
Mitoxantrone—Discomfort—Memantine—Alzheimer's disease	0.000833	0.00186	CcSEcCtD
Mitoxantrone—Hypotension—Donepezil—Alzheimer's disease	0.000832	0.00186	CcSEcCtD
Mitoxantrone—ABCG2—cerebellum—Alzheimer's disease	0.000827	0.0135	CbGeAlD
Mitoxantrone—Arthralgia—Rivastigmine—Alzheimer's disease	0.000825	0.00184	CcSEcCtD
Mitoxantrone—Chest pain—Rivastigmine—Alzheimer's disease	0.000825	0.00184	CcSEcCtD
Mitoxantrone—Myalgia—Rivastigmine—Alzheimer's disease	0.000825	0.00184	CcSEcCtD
Mitoxantrone—Asthenia—Galantamine—Alzheimer's disease	0.000824	0.00184	CcSEcCtD
Mitoxantrone—Anxiety—Rivastigmine—Alzheimer's disease	0.000822	0.00184	CcSEcCtD
Mitoxantrone—Confusional state—Memantine—Alzheimer's disease	0.000815	0.00182	CcSEcCtD
Mitoxantrone—Discomfort—Rivastigmine—Alzheimer's disease	0.000815	0.00182	CcSEcCtD
Mitoxantrone—ABCC1—brain—Alzheimer's disease	0.000812	0.0132	CbGeAlD
Mitoxantrone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000811	0.00181	CcSEcCtD
Mitoxantrone—Oedema—Memantine—Alzheimer's disease	0.000809	0.00181	CcSEcCtD
Mitoxantrone—Infection—Memantine—Alzheimer's disease	0.000803	0.0018	CcSEcCtD
Mitoxantrone—Paraesthesia—Donepezil—Alzheimer's disease	0.0008	0.00179	CcSEcCtD
Mitoxantrone—ABCB1—forebrain—Alzheimer's disease	0.000798	0.013	CbGeAlD
Mitoxantrone—Confusional state—Rivastigmine—Alzheimer's disease	0.000798	0.00178	CcSEcCtD
Mitoxantrone—Shock—Memantine—Alzheimer's disease	0.000796	0.00178	CcSEcCtD
Mitoxantrone—Dyspnoea—Donepezil—Alzheimer's disease	0.000794	0.00178	CcSEcCtD
Mitoxantrone—Somnolence—Donepezil—Alzheimer's disease	0.000792	0.00177	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Memantine—Alzheimer's disease	0.000792	0.00177	CcSEcCtD
Mitoxantrone—Oedema—Rivastigmine—Alzheimer's disease	0.000791	0.00177	CcSEcCtD
Mitoxantrone—Tachycardia—Memantine—Alzheimer's disease	0.000789	0.00176	CcSEcCtD
Mitoxantrone—Diarrhoea—Galantamine—Alzheimer's disease	0.000786	0.00176	CcSEcCtD
Mitoxantrone—Infection—Rivastigmine—Alzheimer's disease	0.000786	0.00176	CcSEcCtD
Mitoxantrone—Skin disorder—Memantine—Alzheimer's disease	0.000785	0.00176	CcSEcCtD
Mitoxantrone—Dyspepsia—Donepezil—Alzheimer's disease	0.000784	0.00175	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000782	0.00175	CcSEcCtD
Mitoxantrone—Shock—Rivastigmine—Alzheimer's disease	0.000778	0.00174	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000774	0.00173	CcSEcCtD
Mitoxantrone—Decreased appetite—Donepezil—Alzheimer's disease	0.000774	0.00173	CcSEcCtD
Mitoxantrone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000772	0.00173	CcSEcCtD
Mitoxantrone—Anorexia—Memantine—Alzheimer's disease	0.000771	0.00172	CcSEcCtD
Mitoxantrone—Skin disorder—Rivastigmine—Alzheimer's disease	0.000768	0.00172	CcSEcCtD
Mitoxantrone—Fatigue—Donepezil—Alzheimer's disease	0.000768	0.00172	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000765	0.00171	CcSEcCtD
Mitoxantrone—Constipation—Donepezil—Alzheimer's disease	0.000762	0.0017	CcSEcCtD
Mitoxantrone—Pain—Donepezil—Alzheimer's disease	0.000762	0.0017	CcSEcCtD
Mitoxantrone—CYP2E1—nervous system—Alzheimer's disease	0.000761	0.0124	CbGeAlD
Mitoxantrone—Hypotension—Memantine—Alzheimer's disease	0.000756	0.00169	CcSEcCtD
Mitoxantrone—Anorexia—Rivastigmine—Alzheimer's disease	0.000754	0.00169	CcSEcCtD
Mitoxantrone—Hypotension—Rivastigmine—Alzheimer's disease	0.000739	0.00165	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000737	0.00165	CcSEcCtD
Mitoxantrone—ABCB1—telencephalon—Alzheimer's disease	0.000734	0.012	CbGeAlD
Mitoxantrone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000734	0.00164	CcSEcCtD
Mitoxantrone—CYP2E1—central nervous system—Alzheimer's disease	0.000733	0.0119	CbGeAlD
Mitoxantrone—Vomiting—Galantamine—Alzheimer's disease	0.000731	0.00163	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000728	0.00163	CcSEcCtD
Mitoxantrone—Paraesthesia—Memantine—Alzheimer's disease	0.000726	0.00162	CcSEcCtD
Mitoxantrone—Rash—Galantamine—Alzheimer's disease	0.000725	0.00162	CcSEcCtD
Mitoxantrone—Dermatitis—Galantamine—Alzheimer's disease	0.000724	0.00162	CcSEcCtD
Mitoxantrone—Dyspnoea—Memantine—Alzheimer's disease	0.000721	0.00161	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000721	0.00161	CcSEcCtD
Mitoxantrone—Headache—Galantamine—Alzheimer's disease	0.00072	0.00161	CcSEcCtD
Mitoxantrone—Somnolence—Memantine—Alzheimer's disease	0.000719	0.00161	CcSEcCtD
Mitoxantrone—CYP2E1—cerebellum—Alzheimer's disease	0.000716	0.0117	CbGeAlD
Mitoxantrone—Dyspepsia—Memantine—Alzheimer's disease	0.000712	0.00159	CcSEcCtD
Mitoxantrone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00071	0.00159	CcSEcCtD
Mitoxantrone—Urticaria—Donepezil—Alzheimer's disease	0.000707	0.00158	CcSEcCtD
Mitoxantrone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000705	0.00158	CcSEcCtD
Mitoxantrone—Abdominal pain—Donepezil—Alzheimer's disease	0.000704	0.00157	CcSEcCtD
Mitoxantrone—Body temperature increased—Donepezil—Alzheimer's disease	0.000704	0.00157	CcSEcCtD
Mitoxantrone—Somnolence—Rivastigmine—Alzheimer's disease	0.000703	0.00157	CcSEcCtD
Mitoxantrone—Decreased appetite—Memantine—Alzheimer's disease	0.000703	0.00157	CcSEcCtD
Mitoxantrone—Fatigue—Memantine—Alzheimer's disease	0.000697	0.00156	CcSEcCtD
Mitoxantrone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000696	0.00156	CcSEcCtD
Mitoxantrone—Constipation—Memantine—Alzheimer's disease	0.000691	0.00155	CcSEcCtD
Mitoxantrone—Pain—Memantine—Alzheimer's disease	0.000691	0.00155	CcSEcCtD
Mitoxantrone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000688	0.00154	CcSEcCtD
Mitoxantrone—Nausea—Galantamine—Alzheimer's disease	0.000683	0.00153	CcSEcCtD
Mitoxantrone—Fatigue—Rivastigmine—Alzheimer's disease	0.000682	0.00152	CcSEcCtD
Mitoxantrone—Pain—Rivastigmine—Alzheimer's disease	0.000676	0.00151	CcSEcCtD
Mitoxantrone—Constipation—Rivastigmine—Alzheimer's disease	0.000676	0.00151	CcSEcCtD
Mitoxantrone—ABCG2—brain—Alzheimer's disease	0.000672	0.0109	CbGeAlD
Mitoxantrone—Feeling abnormal—Memantine—Alzheimer's disease	0.000666	0.00149	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000661	0.00148	CcSEcCtD
Mitoxantrone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000656	0.00147	CcSEcCtD
Mitoxantrone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000652	0.00146	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000647	0.00145	CcSEcCtD
Mitoxantrone—Urticaria—Memantine—Alzheimer's disease	0.000642	0.00144	CcSEcCtD
Mitoxantrone—Body temperature increased—Memantine—Alzheimer's disease	0.000639	0.00143	CcSEcCtD
Mitoxantrone—Abdominal pain—Memantine—Alzheimer's disease	0.000639	0.00143	CcSEcCtD
Mitoxantrone—Asthenia—Donepezil—Alzheimer's disease	0.000639	0.00143	CcSEcCtD
Mitoxantrone—Urticaria—Rivastigmine—Alzheimer's disease	0.000628	0.0014	CcSEcCtD
Mitoxantrone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000625	0.0014	CcSEcCtD
Mitoxantrone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000625	0.0014	CcSEcCtD
Mitoxantrone—CYP3A4—nervous system—Alzheimer's disease	0.000612	0.00997	CbGeAlD
Mitoxantrone—Diarrhoea—Donepezil—Alzheimer's disease	0.000609	0.00136	CcSEcCtD
Mitoxantrone—Hypersensitivity—Memantine—Alzheimer's disease	0.000596	0.00133	CcSEcCtD
Mitoxantrone—CYP3A4—central nervous system—Alzheimer's disease	0.00059	0.0096	CbGeAlD
Mitoxantrone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000583	0.0013	CcSEcCtD
Mitoxantrone—CYP2E1—brain—Alzheimer's disease	0.000582	0.00947	CbGeAlD
Mitoxantrone—Asthenia—Memantine—Alzheimer's disease	0.00058	0.0013	CcSEcCtD
Mitoxantrone—Asthenia—Rivastigmine—Alzheimer's disease	0.000568	0.00127	CcSEcCtD
Mitoxantrone—Vomiting—Donepezil—Alzheimer's disease	0.000566	0.00127	CcSEcCtD
Mitoxantrone—Rash—Donepezil—Alzheimer's disease	0.000562	0.00126	CcSEcCtD
Mitoxantrone—Dermatitis—Donepezil—Alzheimer's disease	0.000561	0.00125	CcSEcCtD
Mitoxantrone—Headache—Donepezil—Alzheimer's disease	0.000558	0.00125	CcSEcCtD
Mitoxantrone—Diarrhoea—Memantine—Alzheimer's disease	0.000553	0.00124	CcSEcCtD
Mitoxantrone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000541	0.00121	CcSEcCtD
Mitoxantrone—Nausea—Donepezil—Alzheimer's disease	0.000529	0.00118	CcSEcCtD
Mitoxantrone—Vomiting—Memantine—Alzheimer's disease	0.000514	0.00115	CcSEcCtD
Mitoxantrone—Rash—Memantine—Alzheimer's disease	0.00051	0.00114	CcSEcCtD
Mitoxantrone—Dermatitis—Memantine—Alzheimer's disease	0.000509	0.00114	CcSEcCtD
Mitoxantrone—Headache—Memantine—Alzheimer's disease	0.000507	0.00113	CcSEcCtD
Mitoxantrone—Vomiting—Rivastigmine—Alzheimer's disease	0.000503	0.00112	CcSEcCtD
Mitoxantrone—Rash—Rivastigmine—Alzheimer's disease	0.000499	0.00112	CcSEcCtD
Mitoxantrone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000498	0.00111	CcSEcCtD
Mitoxantrone—Headache—Rivastigmine—Alzheimer's disease	0.000496	0.00111	CcSEcCtD
Mitoxantrone—Nausea—Memantine—Alzheimer's disease	0.00048	0.00107	CcSEcCtD
Mitoxantrone—Nausea—Rivastigmine—Alzheimer's disease	0.00047	0.00105	CcSEcCtD
Mitoxantrone—ABCB1—nervous system—Alzheimer's disease	0.000433	0.00706	CbGeAlD
Mitoxantrone—ABCB1—central nervous system—Alzheimer's disease	0.000417	0.00679	CbGeAlD
Mitoxantrone—ABCB1—cerebellum—Alzheimer's disease	0.000408	0.00664	CbGeAlD
Mitoxantrone—ABCB1—brain—Alzheimer's disease	0.000331	0.00539	CbGeAlD
Mitoxantrone—CYP2E1—Metabolism—GAPDHS—Alzheimer's disease	7.46e-05	0.000267	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	7.38e-05	0.000265	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	7.33e-05	0.000263	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TPI1—Alzheimer's disease	7.32e-05	0.000263	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—MAPK8—Alzheimer's disease	7.18e-05	0.000258	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CALM1—Alzheimer's disease	7.18e-05	0.000258	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	7.09e-05	0.000254	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ATP5A1—Alzheimer's disease	7.07e-05	0.000254	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—DHCR24—Alzheimer's disease	7.02e-05	0.000252	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	6.97e-05	0.00025	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.94e-05	0.000249	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—IL6—Alzheimer's disease	6.94e-05	0.000249	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EIF2AK2—Alzheimer's disease	6.88e-05	0.000247	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GAPDH—Alzheimer's disease	6.75e-05	0.000242	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLD3—Alzheimer's disease	6.74e-05	0.000242	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	6.67e-05	0.000239	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	6.66e-05	0.000239	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HSD17B10—Alzheimer's disease	6.46e-05	0.000232	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	6.45e-05	0.000232	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	6.4e-05	0.000229	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PSEN2—Alzheimer's disease	6.32e-05	0.000227	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP46A1—Alzheimer's disease	6.22e-05	0.000223	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—GSK3B—Alzheimer's disease	6.2e-05	0.000222	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CST3—Alzheimer's disease	6.18e-05	0.000222	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CREB1—Alzheimer's disease	6.15e-05	0.000221	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CHAT—Alzheimer's disease	6.13e-05	0.00022	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TPI1—Alzheimer's disease	6.13e-05	0.00022	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.1e-05	0.000219	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	6.08e-05	0.000218	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ND1—Alzheimer's disease	6.01e-05	0.000216	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	5.97e-05	0.000214	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA4—Alzheimer's disease	5.97e-05	0.000214	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TPI1—Alzheimer's disease	5.93e-05	0.000213	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CHAT—Alzheimer's disease	5.93e-05	0.000213	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MAOB—Alzheimer's disease	5.88e-05	0.000211	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IAPP—Alzheimer's disease	5.78e-05	0.000207	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MAOB—Alzheimer's disease	5.68e-05	0.000204	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GAPDH—Alzheimer's disease	5.66e-05	0.000203	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	5.61e-05	0.000201	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.59e-05	0.000201	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	5.55e-05	0.000199	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.54e-05	0.000199	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	5.47e-05	0.000196	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GAPDH—Alzheimer's disease	5.47e-05	0.000196	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—A2M—Alzheimer's disease	5.46e-05	0.000196	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.41e-05	0.000194	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CHAT—Alzheimer's disease	5.39e-05	0.000194	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TPI1—Alzheimer's disease	5.39e-05	0.000194	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.36e-05	0.000192	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	5.32e-05	0.000191	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ENO1—Alzheimer's disease	5.32e-05	0.000191	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PPP3CA—Alzheimer's disease	5.29e-05	0.00019	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—A2M—Alzheimer's disease	5.28e-05	0.00019	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	5.27e-05	0.000189	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MAOB—Alzheimer's disease	5.17e-05	0.000186	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BCL2—Alzheimer's disease	5.16e-05	0.000185	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	5.13e-05	0.000184	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLD3—Alzheimer's disease	5.08e-05	0.000182	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GAB2—Alzheimer's disease	5.07e-05	0.000182	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GSK3A—Alzheimer's disease	5.03e-05	0.00018	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GAPDH—Alzheimer's disease	4.98e-05	0.000179	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APP—Alzheimer's disease	4.94e-05	0.000177	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.87e-05	0.000175	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	4.87e-05	0.000175	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—A2M—Alzheimer's disease	4.81e-05	0.000172	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ACHE—Alzheimer's disease	4.75e-05	0.000171	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	4.72e-05	0.000169	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.71e-05	0.000169	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—INPP5D—Alzheimer's disease	4.7e-05	0.000169	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	4.69e-05	0.000168	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ACHE—Alzheimer's disease	4.6e-05	0.000165	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	4.6e-05	0.000165	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—Alzheimer's disease	4.59e-05	0.000165	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1B—Alzheimer's disease	4.56e-05	0.000164	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—INPP5D—Alzheimer's disease	4.54e-05	0.000163	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ND1—Alzheimer's disease	4.53e-05	0.000162	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ENO1—Alzheimer's disease	4.45e-05	0.00016	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS1—Alzheimer's disease	4.45e-05	0.00016	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP2D6—Alzheimer's disease	4.37e-05	0.000157	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.37e-05	0.000157	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	4.33e-05	0.000155	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS1—Alzheimer's disease	4.31e-05	0.000155	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ENO1—Alzheimer's disease	4.31e-05	0.000155	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ADAM10—Alzheimer's disease	4.25e-05	0.000153	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—AKT1—Alzheimer's disease	4.23e-05	0.000152	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP2D6—Alzheimer's disease	4.22e-05	0.000152	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK8—Alzheimer's disease	4.18e-05	0.00015	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ACHE—Alzheimer's disease	4.18e-05	0.00015	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—BCHE—Alzheimer's disease	4.14e-05	0.000149	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—INPP5D—Alzheimer's disease	4.13e-05	0.000148	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—AKT1—Alzheimer's disease	4.06e-05	0.000146	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	4.05e-05	0.000145	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—BCHE—Alzheimer's disease	4e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ENO1—Alzheimer's disease	3.92e-05	0.000141	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS1—Alzheimer's disease	3.92e-05	0.000141	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PLCB1—Alzheimer's disease	3.91e-05	0.00014	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TPI1—Alzheimer's disease	3.87e-05	0.000139	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CHAT—Alzheimer's disease	3.87e-05	0.000139	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP2D6—Alzheimer's disease	3.84e-05	0.000138	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.83e-05	0.000137	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCA1—Alzheimer's disease	3.79e-05	0.000136	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PLCB1—Alzheimer's disease	3.78e-05	0.000136	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.73e-05	0.000134	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MAOB—Alzheimer's disease	3.71e-05	0.000133	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.71e-05	0.000133	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.68e-05	0.000132	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCA1—Alzheimer's disease	3.66e-05	0.000131	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—BCHE—Alzheimer's disease	3.64e-05	0.000131	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	3.57e-05	0.000128	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—LPL—Alzheimer's disease	3.55e-05	0.000127	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.46e-05	0.000124	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—A2M—Alzheimer's disease	3.45e-05	0.000124	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PRKCG—Alzheimer's disease	3.45e-05	0.000124	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.44e-05	0.000123	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PLCB1—Alzheimer's disease	3.44e-05	0.000123	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—Alzheimer's disease	3.42e-05	0.000123	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCA1—Alzheimer's disease	3.33e-05	0.00012	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	3.3e-05	0.000118	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.28e-05	0.000118	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CCR5—Alzheimer's disease	3.27e-05	0.000117	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARGC1A—Alzheimer's disease	3.26e-05	0.000117	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HMOX1—Alzheimer's disease	3.25e-05	0.000117	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTHFR—Alzheimer's disease	3.19e-05	0.000115	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARGC1A—Alzheimer's disease	3.16e-05	0.000113	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.16e-05	0.000113	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HMOX1—Alzheimer's disease	3.14e-05	0.000113	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.13e-05	0.000112	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ACHE—Alzheimer's disease	3e-05	0.000108	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3e-05	0.000108	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CALM1—Alzheimer's disease	2.98e-05	0.000107	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOE—Alzheimer's disease	2.97e-05	0.000107	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—LPL—Alzheimer's disease	2.97e-05	0.000107	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	2.97e-05	0.000106	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.95e-05	0.000106	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CAV1—Alzheimer's disease	2.95e-05	0.000106	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TPI1—Alzheimer's disease	2.92e-05	0.000105	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CHAT—Alzheimer's disease	2.92e-05	0.000105	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.89e-05	0.000104	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—LPL—Alzheimer's disease	2.87e-05	0.000103	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARGC1A—Alzheimer's disease	2.87e-05	0.000103	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HMOX1—Alzheimer's disease	2.86e-05	0.000103	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	2.81e-05	0.000101	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ENO1—Alzheimer's disease	2.81e-05	0.000101	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MAOB—Alzheimer's disease	2.8e-05	0.0001	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.79e-05	0.0001	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS2—Alzheimer's disease	2.77e-05	9.94e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	2.76e-05	9.9e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOTCH1—Alzheimer's disease	2.74e-05	9.85e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GAPDH—Alzheimer's disease	2.69e-05	9.66e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—Alzheimer's disease	2.68e-05	9.6e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—Alzheimer's disease	2.67e-05	9.59e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—BCHE—Alzheimer's disease	2.62e-05	9.38e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—LPL—Alzheimer's disease	2.61e-05	9.38e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—A2M—Alzheimer's disease	2.6e-05	9.32e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.6e-05	9.32e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—Alzheimer's disease	2.59e-05	9.28e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GSK3B—Alzheimer's disease	2.58e-05	9.24e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CREB1—Alzheimer's disease	2.56e-05	9.17e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—INS—Alzheimer's disease	2.54e-05	9.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CALM1—Alzheimer's disease	2.5e-05	8.97e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOE—Alzheimer's disease	2.49e-05	8.94e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	2.47e-05	8.86e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CAV1—Alzheimer's disease	2.47e-05	8.85e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—Alzheimer's disease	2.47e-05	8.84e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CALM1—Alzheimer's disease	2.42e-05	8.67e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOE—Alzheimer's disease	2.41e-05	8.64e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	2.39e-05	8.58e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CAV1—Alzheimer's disease	2.39e-05	8.56e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—Alzheimer's disease	2.35e-05	8.45e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ACHE—Alzheimer's disease	2.26e-05	8.11e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—INPP5D—Alzheimer's disease	2.24e-05	8.02e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS3—Alzheimer's disease	2.23e-05	7.99e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CALM1—Alzheimer's disease	2.2e-05	7.89e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.19e-05	7.87e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOE—Alzheimer's disease	2.19e-05	7.86e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CAV1—Alzheimer's disease	2.17e-05	7.79e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARG—Alzheimer's disease	2.17e-05	7.78e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—INS—Alzheimer's disease	2.13e-05	7.63e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ENO1—Alzheimer's disease	2.12e-05	7.6e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS1—Alzheimer's disease	2.12e-05	7.6e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARG—Alzheimer's disease	2.1e-05	7.53e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	2.08e-05	7.45e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	2.06e-05	7.4e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—INS—Alzheimer's disease	2.06e-05	7.38e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	2.05e-05	7.36e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—Alzheimer's disease	2.04e-05	7.31e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.97e-05	7.07e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARG—Alzheimer's disease	1.91e-05	6.85e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—LPL—Alzheimer's disease	1.88e-05	6.74e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—INS—Alzheimer's disease	1.87e-05	6.72e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NOS3—Alzheimer's disease	1.87e-05	6.69e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.86e-05	6.67e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NOS3—Alzheimer's disease	1.8e-05	6.48e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.8e-05	6.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.8e-05	6.45e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.8e-05	6.45e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.72e-05	6.18e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—Alzheimer's disease	1.71e-05	6.12e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	1.69e-05	6.06e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.66e-05	5.95e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—Alzheimer's disease	1.65e-05	5.92e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NOS3—Alzheimer's disease	1.64e-05	5.89e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.6e-05	5.75e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CALM1—Alzheimer's disease	1.58e-05	5.67e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOE—Alzheimer's disease	1.57e-05	5.65e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CAV1—Alzheimer's disease	1.56e-05	5.59e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.55e-05	5.57e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.55e-05	5.55e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—Alzheimer's disease	1.5e-05	5.39e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—Alzheimer's disease	1.47e-05	5.29e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LPL—Alzheimer's disease	1.41e-05	5.07e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.39e-05	5e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.38e-05	4.94e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARG—Alzheimer's disease	1.37e-05	4.92e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—INS—Alzheimer's disease	1.34e-05	4.82e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.31e-05	4.68e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.31e-05	4.68e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.28e-05	4.59e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.27e-05	4.57e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.21e-05	4.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.19e-05	4.27e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOE—Alzheimer's disease	1.19e-05	4.25e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NOS3—Alzheimer's disease	1.18e-05	4.23e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.17e-05	4.21e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.15e-05	4.11e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—Alzheimer's disease	1.11e-05	3.98e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.11e-05	3.98e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.08e-05	3.87e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.03e-05	3.7e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—Alzheimer's disease	1.02e-05	3.67e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—INS—Alzheimer's disease	1.01e-05	3.63e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	9.57e-06	3.43e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	9.52e-06	3.42e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NOS3—Alzheimer's disease	8.88e-06	3.19e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LPL—Alzheimer's disease	8.71e-06	3.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—Alzheimer's disease	8.58e-06	3.08e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—Alzheimer's disease	8.3e-06	2.98e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—Alzheimer's disease	8.12e-06	2.91e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	7.84e-06	2.81e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—Alzheimer's disease	7.55e-06	2.71e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	7.33e-06	2.63e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOE—Alzheimer's disease	7.3e-06	2.62e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.23e-06	2.6e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.36e-06	2.28e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—INS—Alzheimer's disease	6.24e-06	2.24e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	5.47e-06	1.96e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—Alzheimer's disease	5.42e-06	1.94e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5e-06	1.79e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—Alzheimer's disease	4.08e-06	1.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.51e-06	9.02e-06	CbGpPWpGaD
